beta-lactams has been researched along with fosfomycin in 35 studies
Studies (beta-lactams) | Trials (beta-lactams) | Recent Studies (post-2010) (beta-lactams) | Studies (fosfomycin) | Trials (fosfomycin) | Recent Studies (post-2010) (fosfomycin) |
---|---|---|---|---|---|
7,579 | 179 | 3,395 | 2,335 | 181 | 1,022 |
Protein | Taxonomy | beta-lactams (IC50) | fosfomycin (IC50) |
---|---|---|---|
UDP-N-acetylglucosamine 1-carboxyvinyltransferase | Escherichia coli K-12 | 3.5795 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (22.86) | 18.7374 |
1990's | 4 (11.43) | 18.2507 |
2000's | 6 (17.14) | 29.6817 |
2010's | 15 (42.86) | 24.3611 |
2020's | 2 (5.71) | 2.80 |
Authors | Studies |
---|---|
Olay, T; Quecedo, MC; Rodríguez, A; Vicente, MV | 1 |
Borowski, J; Linda, H | 1 |
Lebreton, P; Malbruny, B; Morel, C; Nigam, M; Vergnaud, M; Zerr, C | 1 |
Klein, U; Opferkuch, W; Pawelzik, M | 1 |
Bercion, R; Buisson, Y; Hugard, L; Mauclère, P; Schill, H | 1 |
Traub, WH | 2 |
Schröter, G; Strobel, I | 1 |
Aucouturier, C; Caron, F; Lemeland, JF; Martin, E; Pestel, M | 1 |
Chakrabarty, AN; Dastidar, SG; Mazumdar, A; Mookerjee, M | 1 |
Chen, J; Nakamura, A; O'Hara, K; Sawai, T; Shigenobu, F | 1 |
Nakanishi, T; Nasu, T; Nishino, T; Okamoto, K | 1 |
Cavallo, JD; Fabre, R; Hance, P; Leblanc, F | 1 |
Asseray, N; Berthelot, JM; Boutoille, D; Gillard, J; Maugars, Y; Varin, S | 1 |
Arrigucci, S; Cassetta, MI; Fallani, S; Mazzei, T; Novelli, A | 1 |
Fariñas, MC; García-Palomo, D; Horcajada, JP | 1 |
Herrera, ML; Jorgensen, JH; Lewis, JS; Prakash, V; Wickes, BL | 1 |
Hagane, K; Hanaki, H; Hashimoto, T; Ikeda-Dantsuji, Y; Ishizaki, A; Kageyama, Y; Kawaguchi, T; Kawajiri, H; Ono, T; Sato, S; Sugahara, K; Sunakawa, K; Tachihara-Sato, R; Takahashi, Y; Tamura, A; Yamaguchi, Y; Yanagisawa, C; Yanagisawa, T; Yazaki, H | 1 |
Hsu, MS; Hsueh, PR; Huang, YT; Liao, CH; Liu, CY; Yang, CJ | 1 |
Ahmed-Bentley, J; Peirano, G; Pitout, JD; Woodford, N | 1 |
Abdelali, S; Abdelouahid, DE; Azzaoui, H; Rahmoun, M; Rebiahi, SA | 1 |
Burian, A; Erdogan, Z; Jandrisits, C; Zeitlinger, M | 1 |
Ono, Y | 1 |
Alberola, J; Artero, A; Cano, A; Eiros, JM; Nogueira, JM | 1 |
Alvarez-Rocha, L; Arias, J; Azanza, JR; Barberán, J; Candel, F; de Alarcón, CA; Fortún, J; García, JE; Gómez, J; Grau, S; Llinares, P; Marco, F; Maseda, E; Mensa, J; Montejo, M; Moreno, A; Parra, J; Pasquau, J; Picazo, J; Salavert, M; Soriano, A; Soy, D | 1 |
Bastide, C; Bernard, L; Bruyère, F; Chaussade, H; Coloby, P; Guy, L; Karsenty, G; Sunder, S | 1 |
Falagas, ME; Trigkidis, KK; Vardakas, KZ | 1 |
Bartoloni, A; Di Maggio, T; Di Pilato, V; Pallecchi, L; Revollo, C; Riccobono, E; Rossolini, GM | 1 |
Graves, B; Hajkowicz, K; Paterson, DL; Stewart, A; Ta, K | 1 |
Samuelsen, Ø; Småbrekke, L; Sundsfjord, A; Zykov, IN | 1 |
Davis, SL; Grunwald, JL; Kenney, RM; Veve, MP; Wagner, JL | 1 |
Bader, MS; Brooks, AA; Loeb, M | 1 |
Chu, CM; Lowder, JL | 1 |
Alessio, P; Cimino, S; Imbimbo, C; Migliara, A; Mirone, V; Morgia, G; Russo, GI; Venturino, L; Verze, P | 1 |
Cai, Y; Jia, Y; Wang, J; Yan, K; Zhu, M | 1 |
7 review(s) available for beta-lactams and fosfomycin
Article | Year |
---|---|
[Treatment of uncomplicated lower urinary tract infections].
Topics: Administration, Oral; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Cephalosporins; Cystitis; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Fosfomycin; Humans; Nitrofurantoin; Practice Guidelines as Topic; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2005 |
[Guidelines for antimicrobial treatment of the infection by Staphylococcus aureus].
Topics: Acetamides; Aminoglycosides; Animals; Anti-Bacterial Agents; beta-Lactams; Clindamycin; Daptomycin; Disease Models, Animal; Fluoroquinolones; Fosfomycin; Guidelines as Topic; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Tetracyclines; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2013 |
[Antibiotic treatments in urology].
Topics: Anti-Bacterial Agents; beta-Lactams; Fosfomycin; Glycopeptides; Humans; Nitrofurans; Paromomycin; Quinolones; Tetracyclines; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2013 |
Inhaled antibiotics beyond aminoglycosides, polymyxins and aztreonam: A systematic review.
Topics: Administration, Inhalation; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Bronchiectasis; Cystic Fibrosis; Fosfomycin; Humans; Pneumonia, Ventilator-Associated; Quinolones; Respiratory Tract Infections; Treatment Outcome | 2015 |
An update on the management of urinary tract infections in the era of antimicrobial resistance.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Comorbidity; Drug Resistance, Bacterial; Fluoroquinolones; Fosfomycin; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Minocycline; Nitrofurantoin; Severity of Illness Index; Urinary Tract Infections | 2017 |
Diagnosis and treatment of urinary tract infections across age groups.
Topics: Adult; Age Factors; Aged; Anti-Bacterial Agents; Antimicrobial Stewardship; Asymptomatic Infections; Bacteriuria; beta-Lactams; Culture Techniques; Drug Resistance, Bacterial; Female; Fluoroquinolones; Fosfomycin; Humans; Lower Urinary Tract Symptoms; Middle Aged; Nitrites; Nitrofurantoin; Pregnancy; Pregnancy Complications, Infectious; Pyuria; Trimethoprim, Sulfamethoxazole Drug Combination; Urinalysis; Urinary Tract Infections | 2018 |
Efficacy and safety of quinolones vs. other antimicrobials for the treatment of uncomplicated urinary tract infections in adults: a systematic review and meta-analysis.
Topics: Adult; Anti-Infective Agents; beta-Lactams; Fosfomycin; Humans; Nitrofurantoin; Quinolones; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2022 |
28 other study(ies) available for beta-lactams and fosfomycin
Article | Year |
---|---|
Diffusion of beta-lactam antibiotics and fosfomycin to interstitial tissue fluid in rabbits.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Body Fluids; Female; Fosfomycin; Half-Life; Hydrogen-Ion Concentration; Injections, Intramuscular; Male; Molecular Weight; Protein Binding; Rabbits | 1979 |
Combined action of fosfomycin with beta-lactam and aminoglycoside antibiotics.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactams; Drug Synergism; Escherichia coli; Fosfomycin; Penicillin G; Penicillin Resistance; Staphylococcus aureus; Streptomycin | 1977 |
[Use of an antibioprophylaxis with pefloxacin and fosfomycin in cardiac surgery in patients with beta-lactam hypersensitivity].
Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Cardiac Surgical Procedures; Drug Hypersensitivity; Drug Therapy, Combination; Female; Fosfomycin; Humans; Male; Middle Aged; Pefloxacin; Premedication | 1989 |
Influence of beta-lactam antibiotics, fosfomycin and vancomycin on the adherence (hemagglutination) of Escherichia coli-containing different adhesins.
Topics: Adhesiveness; Anti-Bacterial Agents; beta-Lactams; Escherichia coli; Fimbriae, Bacterial; Fosfomycin; Hemagglutination Tests; Vancomycin | 1985 |
[Preliminary study of the antagonistic effects between fosfomycin and beta-lactams on Pseudomonas aeruginosa observed on the antibiogram].
Topics: Anti-Bacterial Agents; beta-Lactams; Drug Antagonism; Drug Therapy, Combination; Fosfomycin; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections | 1988 |
Interactions of antimicrobial drugs and combined phagocytic/serum bactericidal activity of defibrinated human blood against Serratia marcescens. III. beta-Lactam antibiotics and fosfomycin.
Topics: Anti-Bacterial Agents; beta-Lactams; Blood Bactericidal Activity; Fibrin; Fosfomycin; Humans; Microbial Sensitivity Tests; Phagocytosis; Serratia marcescens | 1983 |
In vitro susceptibility of Eikenella corrodens to thirteen beta-lactam antibiotics and fosfomycin.
Topics: Anti-Bacterial Agents; Bacteroides; beta-Lactams; Eikenella corrodens; Fosfomycin; Microbial Sensitivity Tests | 1983 |
Variable tolerance of a clinical isolate of Staphylococcus epidermidis from an infected hydrocephalus shunt for several beta-lactam antibiotics, vancomycin and fosfomycin.
Topics: Anti-Bacterial Agents; beta-Lactams; Cerebrospinal Fluid Shunts; Drug Resistance, Microbial; Fosfomycin; Humans; Hydrocephalus; Infant; Microbial Sensitivity Tests; Staphylococcus; Vancomycin | 1981 |
In vitro interactions between different beta-lactam antibiotics and fosfomycin against bloodstream isolates of enterococci.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Drug Therapy, Combination; Enterococcus; Fosfomycin; Microbial Sensitivity Tests | 1995 |
Antimicrobial potentiality of a new beta-lactum antibiotic fosfomycin.
Topics: Anti-Bacterial Agents; beta-Lactams; Fosfomycin; Microbial Sensitivity Tests | 1997 |
[Combination effect of fosfomycin to beta-lactam, aminoglycoside, and macrolide antibiotics against clinical isolates of Klebsiella pneumoniae].
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Microbial; Drug Synergism; Fosfomycin; Klebsiella pneumoniae; Macrolides; Microbial Sensitivity Tests | 1997 |
[In vitro antibacterial activity of faropenem, a novel oral penem antibiotic, against enterohemorrhagic Escherichia coli O157 strains].
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacterial Toxins; beta-Lactams; Cefdinir; Cephalosporins; Clarithromycin; Escherichia coli O157; Fosfomycin; Kanamycin; Lactams; Microbial Sensitivity Tests; Minocycline; Norfloxacin; Shiga Toxin 1 | 1999 |
[Correlation between sensitivity to fosfomycin and the presence of penicillinase PSE-1 in Pseudomonas aeruginosa].
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Microbial; Fosfomycin; Hospitals, Teaching; Microbial Sensitivity Tests; Penicillinase; Pseudomonas aeruginosa; Serotyping | 2001 |
Suspected disk space infection with negative microbiological tests-report of eight cases and comparison with documented pyogenic discitis.
Topics: Abscess; Aged; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Discitis; Drug Therapy, Combination; Female; Fluoroquinolones; Fosfomycin; Humans; Injections, Intravenous; Male; Middle Aged; Retrospective Studies; Risk Factors | 2005 |
Pharmacokinetic and pharmacodynamic aspects of antimicrobial agents for the treatment of uncomplicated urinary tract infections.
Topics: Anti-Infective Agents; beta-Lactams; Fluoroquinolones; Fosfomycin; Humans; Nitrofurantoin; Quinolones; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2006 |
Oral and parenteral therapeutic options for outpatient urinary infections caused by enterobacteriaceae producing CTX-M extended-spectrum beta-lactamases.
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefdinir; Cephalosporins; Cross Infection; Enterobacteriaceae; Ertapenem; Escherichia coli; Fosfomycin; Humans; Infusions, Parenteral; Microbial Sensitivity Tests; Outpatients; Urinary Tract Infections | 2009 |
Characterization of beta-lactam antibiotic-induced vancomycin-resistant MRSA (BIVR) in a patient with septicemia during long-term vancomycin administration.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactams; Dibekacin; Drug Therapy, Combination; Fosfomycin; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Staphylococcal Infections; Time Factors; Vancomycin; Vancomycin Resistance | 2009 |
In vitro susceptibilities of clinical isolates of ertapenem-non-susceptible Enterobacteriaceae to nemonoxacin, tigecycline, fosfomycin and other antimicrobial agents.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Fosfomycin; Humans; Microbial Sensitivity Tests; Minocycline; Quinolones; Tigecycline | 2011 |
New Delhi metallo-beta-lactamase from traveler returning to Canada.
Topics: Adult; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Canada; Carbapenems; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Fosfomycin; Humans; India; Male; Microbial Sensitivity Tests; Prostatitis; Pyelonephritis; Travel; Urine | 2011 |
Emergence of vancomycin-resistant Staphylococcus aureus identified in the Tlemcen university hospital (North-West Algeria).
Topics: Adult; Aged; Algeria; Aminoglycosides; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Cross Infection; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Female; Fosfomycin; Gentamicins; Hospitals, University; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Rifampin; Staphylococcal Infections; Surgical Wound Infection; Vancomycin; Vancomycin Resistance | 2011 |
Impact of pH on activity of trimethoprim, fosfomycin, amikacin, colistin and ertapenem in human urine.
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; beta-Lactams; Colistin; Ertapenem; Fosfomycin; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Trimethoprim; Urine | 2012 |
[Antibiotics].
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Chloramphenicol; Fosfomycin; Glycopeptides; Humans; Ketolides; Linezolid; Macrolides; Oxazolidinones; Peptides; Streptogramins; Tetracyclines; Trimethoprim, Sulfamethoxazole Drug Combination | 2012 |
Pyelonephritis in pregnancy. How adequate is empirical treatment?
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactams; Comorbidity; Escherichia coli Infections; Female; Fosfomycin; Hospitals, University; Humans; Inappropriate Prescribing; Microbial Sensitivity Tests; Obstetrics and Gynecology Department, Hospital; Pregnancy; Pregnancy Complications, Infectious; Pyelonephritis; Recurrence; Retrospective Studies; Spain; Treatment Outcome; Young Adult | 2013 |
Characterization of IncI1 sequence type 71 epidemic plasmid lineage responsible for the recent dissemination of CTX-M-65 extended-spectrum β-lactamase in the Bolivian Chaco region.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Enterobacter cloacae; Enterobacteriaceae; Escherichia coli; Fosfomycin; Klebsiella oxytoca; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Salmonella enterica | 2015 |
The Use of Therapeutic Drug Monitoring to Optimize Treatment of Carbapenem-Resistant Enterobacter Osteomyelitis.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; C-Reactive Protein; Drug Monitoring; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Ertapenem; Female; Fosfomycin; Humans; Meropenem; Middle Aged; Osteomyelitis; Staphylococcal Infections; Staphylococcus epidermidis; Thienamycins | 2015 |
The antimicrobial activity of mecillinam, nitrofurantoin, temocillin and fosfomycin and comparative analysis of resistance patterns in a nationwide collection of ESBL-producing Escherichia coli in Norway 2010-2011.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Fosfomycin; Humans; Microbial Sensitivity Tests; Nitrofurantoin; Norway; Polymerase Chain Reaction; Sequence Analysis, DNA | 2016 |
Comparison of fosfomycin to ertapenem for outpatient or step-down therapy of extended-spectrum β-lactamase urinary tract infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Fosfomycin; Humans; Male; Middle Aged; Outpatients; Patient Readmission; Retrospective Studies; Treatment Outcome; Urinary Tract Infections; Young Adult | 2016 |
Complication Rate After Antibiotic Prophylaxis with Fosfomycin Versus Fluorochinolones or β-lactam Antibiotics in Patients Undergoing Prostate Biopsy: A Propensity Score-adjusted Analysis.
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Cohort Studies; Fluoroquinolones; Fosfomycin; Humans; Image-Guided Biopsy; Male; Middle Aged; Propensity Score; Prostate; Urinary Tract Infections | 2020 |